A federal jury has handed a win to North Chicago-based drugmaker Abbvie, as it continues to seek to fend off a mass of legal claims accusing the company’s testosterone replacement therapy drug, Androgel, of causing heart attacks and other cardiovascular conditions. On June 14, the Chicago jury found Abbvie not liable for any of the medical conditions plaintiff Robert Rowley…
Etzler Lawhead Legal Group, PCJune 26, 2018